Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Predilatation and TAVI
Author(s): Matteo Pagnesi , Luca Baldetti , Paolo Del Sole , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has become an established treatment option for patients with severe, symptomatic aortic stenosis at high or intermediate surgical risk.1–4 From the very beginning of TAVI technology, valve preparation by performing pre-implantation balloon aortic valvuloplasty (pre-BAV) has been considered a necessary step to facilitate device implantation and ensure… View more

Vascular Disease and Surgery

Intervention
Sex and Transcatheter Aortic Valve Implantation
Author(s): Alessandra Laricchia , Barbara Bellini , Vittorio Romano , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is included in guidelines for the treatment of severe symptomatic aortic stenosis (AS) in patients with intermediate to high risk for standard surgical therapy.1 The gender-related difference in the pathophysiology of heart disease (and consequently in its clinical course and treatment) has already been identified as an issue in interventional… View more

Demographic
Annular Rupture During TAVI
Author(s): JJ Coughlan , Thomas J Kiernan , Darren Mylotte , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as an alternative treatment for symptomatic severe aortic stenosis in patients deemed to be at high operative risk for conventional surgical aortic valve replacement (SAVR). In these patients, TAVI has lower all-cause mortality than SAVR1 and recent data also suggest equipoise between these therapies in intermediate-risk patients.2–5… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation
Author(s): Roberto Spina , Chris Anthony , David WM Muller , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high… View more

Vascular Disease and Surgery

Intervention
Moderate Aortic Stenosis: What is it and When Should We Intervene?
Author(s): Sveeta Badiani , Sanjeev Bhattacharyya , Nikoo Aziminia , et al Added: 2 years ago

Imaging & Diagnostics
Author(s): Pascal Thériault-Lauzier , Marco Spaziano , Beatriz Vaquerizo , et al Added: 3 years ago
Valvular Disease Aortic valve Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more

Vascular Disease and Surgery

Intervention
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention
Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation
Author(s): John Phineas O’Donnell , Crochan J O’Sullivan Added: 3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future… View more

Vascular Disease and Surgery

Intervention